Acute Spinal Cord Infarct Secondary to Fibrocartilaginous Embolism Treated With Tenecteplase.

NeurologistSep 1, 2026 (epub)

Jenica Patel, Prasuna Kamireddi, Sneha Jacob

✦ AI-curated · Sources linked

Case in brief

A 56-year-old male with hypertension experienced sudden left arm and leg weakness following a Valsalva maneuver. Examination revealed dense flaccid paralysis. MRI indicated a spinal infarct, and after ruling out other causes, fibrocartilaginous embolism was diagnosed. The patient received thrombolytic therapy and high-dose steroids, resulting in mild improvement. At one-year follow-up, he was able to walk without support and showed some motor recovery.

What made this case unusual

The case illustrates fibrocartilaginous embolism as a rare cause of spinal cord infarction, particularly in a middle-aged patient, which is not commonly reported.

Diagnostic / clinical pearl

Clinicians should consider fibrocartilaginous embolism in the differential diagnosis of acute myelopathy, especially in patients with a history of physical exertion.

Why it matters

This case underscores the need for awareness of atypical causes of spinal cord infarction and the potential role of thrombolytic therapy, which requires further study.

Source

Published in Neurologist. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.